GLPDosing.com exists to make accurate GLP-1 dosing information accessible to the millions of people using compounded semaglutide and tirzepatide. We bridge the gap between clinical prescribing information and what patients actually need to know to use their medication safely and effectively.
All content is developed by our editorial team, which comprises integrative health specialists with backgrounds in integrative nutrition and metabolic health. Team members have direct clinical experience supporting patients navigating GLP-1 medications, compounded peptide formulations, and metabolic health protocols.
See our team page for more detail on our contributors and their areas of expertise.
Our content development process draws on the following primary sources:
We do not rely on anecdotal reports, social media, or forums as primary sources for clinical content.
All content is reviewed by a member of our editorial team before publication. We maintain an internal review schedule to ensure content reflects current clinical standards, updated prescribing information, and new trial data as it becomes available.
We take factual accuracy seriously. If you identify an error in our content, please contact us at hello@glpdosing.com with the specific page and the correction you believe is needed. We review all correction requests promptly and update content when errors are confirmed.
Some pages on GLPDosing.com contain affiliate links to telehealth providers and other services. These relationships do not influence our editorial content. We do not accept payment for positive reviews or editorial coverage. Affiliate links are clearly disclosed on pages where they appear and in our affiliate disclosure.
Provider comparisons are based on publicly available pricing and program information. We do not guarantee the accuracy of third-party pricing data, which may change without notice.
GLPDosing.com is an educational resource only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All dosing and treatment decisions should be made in consultation with a licensed healthcare provider who is familiar with your individual health history and circumstances.
This editorial policy was last reviewed in June 2026.